Healthcare Stocks

HealthcareSurgeon185 AZN: Why AstraZeneca’s Current Dip Is a Buying Opportunity
Source: Flickr
For the past several years, healthcare has been a hot topic of debate. Regardless of whether or not you agree with the Affordable Care Act, your opinion should hold little say in how you play the healthcare stocks in the near future. Despite the controversy over Obamacare, healthcare stocks are playing out to be excellent investments.
With medicine advancing at an astronomical pace, there are many ways to play healthcare stocks. The first way is to invest in the well-known companies like Johnson & Johnson (NYSE:JNJ) which provide a stable investment with decent growth and consistent dividends. The next way to play healthcare stocks is through stocks which offer high potential like Illumina (NADAQ:ILMN), a company that researches genetic functioning. Finally, ETFs like Health Care SPDR (NYSEARCA:XLV) and mutual funds like Fidelity Select Health Care (MUTF:FSPHX) offer limited exposure while still being involved in healthcare.

Healthcare Sector Quote (CIX: MSECTOR5)

Recent Articles

AZN: Why AstraZeneca’s Current Dip Is a Buying Opportunity

Astrazeneca has been investing aggressively in immuno-oncology, which will make AZN stock much more attractive in the long run. More 

3 of the Best Actively Managed Fidelity Funds

Fidelity funds offer a broad selection of low-cost, no-load, actively-managed funds. Here are 3 of their best. More 

Q2 Earnings Season Won’t Be as Ugly as Headlines Suggest

After stripping out the catastrophe that is the energy sector, estimated second-quarter earnings and sales growth isn't half bad. More 

Aetna-Humana Merger Is Bad News For ANTM, CI

Aetna (AET) and Humana (HUM) are getting married. And that may kill the Anthem (ANTM) - Cigna (CI) merger talks. More 

With Obamacare Secured, HCA Has Huge Potential

Now that Obamacare has passed yet another test at the Supreme Court, it looks like select healthcare stocks such as HCA have very bright futures. More 

Supreme Court Gives Healthcare Stocks a Booster Shot

The high court's ACA ruling bolsters the bull case for healthcare stocks, especially hospital companies such as HCA, CYH and THC. More 

Did Alexion Jump the Shark With Its Synageva Bid? (ALXN, GEVA)

While ALXN seems to have overpaid for GEVA on the surface. However, investors can expect to see the benefits over the long-term. More